8 Hrs
Source:
الصحة والعلوم الشرق الأوسط
New drug offers hope for pancreas cancer
A US clinical study has confirmed promising results for a targeted drug aimed at the "KRAS G12D" gene mutation in the treatment of advanced pancreatic cancer. The drug achieved high rates of tumor shrinkage and disease control of up to 96%, without the appearance of unexpected side effects. The results showed that combining the medication with chemotherapy enhances treatment efficacy and elicits a strong response, with cancer markers in the blood decreasing. This offers renewed hope for improving treatment prospects for this disease in the future.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)